MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 95 filers reported holding MAGENTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $15,033 | -90.5% | 38,059 | -65.9% | 0.00% | – |
Q3 2022 | $158,000 | +7.5% | 111,761 | -8.7% | 0.00% | – |
Q2 2022 | $147,000 | -68.7% | 122,387 | -24.5% | 0.00% | – |
Q1 2022 | $470,000 | -43.3% | 162,079 | -13.3% | 0.00% | – |
Q4 2021 | $829,000 | -33.8% | 187,020 | +8.8% | 0.00% | – |
Q3 2021 | $1,252,000 | -16.5% | 171,871 | +12.2% | 0.00% | – |
Q2 2021 | $1,499,000 | +105.3% | 153,225 | +148.8% | 0.00% | – |
Q1 2021 | $730,000 | +20.1% | 61,584 | -20.6% | 0.00% | – |
Q4 2020 | $608,000 | -5.1% | 77,558 | -17.7% | 0.00% | – |
Q3 2020 | $641,000 | +10.9% | 94,236 | +22.4% | 0.00% | – |
Q2 2020 | $578,000 | +114.9% | 76,989 | +79.6% | 0.00% | – |
Q1 2020 | $269,000 | -20.6% | 42,874 | +91.8% | 0.00% | – |
Q4 2019 | $339,000 | +50.0% | 22,348 | +1.4% | 0.00% | – |
Q3 2019 | $226,000 | -36.9% | 22,035 | -9.2% | 0.00% | – |
Q2 2019 | $358,000 | -22.3% | 24,274 | -13.4% | 0.00% | – |
Q1 2019 | $461,000 | +339.0% | 28,018 | +52.7% | 0.00% | – |
Q4 2018 | $105,000 | -89.7% | 18,343 | -75.7% | 0.00% | – |
Q2 2018 | $1,019,000 | – | 75,504 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 8,008,204 | $50,292,000 | 45.98% |
Casdin Capital, LLC | 2,971,034 | $18,658,000 | 1.98% |
Alphabet Inc. | 3,339,138 | $20,970,000 | 1.38% |
Opaleye Management Inc. | 434,712 | $2,730,000 | 0.72% |
Bleichroeder LP | 251,875 | $1,582,000 | 0.41% |
Eventide Asset Management | 1,789,646 | $11,239,000 | 0.36% |
HARVARD MANAGEMENT CO INC | 332,610 | $2,089,000 | 0.33% |
GILDER GAGNON HOWE & CO LLC | 4,059,789 | $25,495,000 | 0.31% |
Leap Investments LP | 12,600 | $79,000 | 0.12% |
Aries Wealth Management | 12,000 | $77,000 | 0.06% |